Rapid Result

Influenza B (Flu B) Antigen Rapid Test

Name: Influenza B (Flu B) Antigen Rapid Test
Brand: reOpenTest
SKU: VIR-FLBAG
Availability: InStock

Quickly detect Influenza B antigens with our rapid test, enabling fast diagnosis and management of flu B infections using nasal swab samples.

CE Certified

ISO 13485

Request Quote View Specs

Main image of Influenza B (Flu B) Antigen Rapid Test

Why Choose reOpenTest Infectious Disease Kits?

Our tests are engineered for accuracy, reliability, and ease of use, ensuring confidence in every result.

Fast Results

Provides results in minutes for prompt diagnosis.

Easy to Use

Simple procedure with minimal training required.

Accurate Detection

High sensitivity and specificity for reliable results.

Product Overview

The Influenza B (Flu B) Antigen Rapid Test is an in vitro diagnostic device designed for the rapid detection of Influenza B virus antigens directly from nasal swab specimens.

Technical Specifications

Detection Target	Influenza B virus antigens
Sample Type	Nasal swab
Methodology	Immunochromatography
Detection Range	Positive/Negative
Reaction Time	10-15 minutes
Storage Conditions	2-30u00b0C
Shelf Life	24 months

Procedure & Interpretation

Step-by-Step Procedure

Collect a nasal swab sample.
Mix the swab with the extraction buffer.
Apply the mixture to the test device.
Read the results after 10-15 minutes.

Result Interpretation

Positive: The presence of both the control line (C) and test line (T) indicates a positive result for Influenza B.

Negative: The presence of only the control line (C) indicates a negative result.

Invalid: If the control line (C) is not visible, the test is invalid and should be repeated.

Frequently Asked Questions

Rapid Influenza B detection enables timely implementation of targeted antiviral treatment strategies and resource allocation, minimizing the spread of influenza B within communities and healthcare facilities.

The test helps healthcare professionals differentiate between influenza A and B, allowing for targeted antiviral treatment strategies and resource allocation, improving patient outcomes and infection control.

Yes, the Influenza B Antigen Rapid Test is a valuable tool for surveillance purposes, enabling healthcare providers and public health agencies to monitor the prevalence of influenza B in different populations and track seasonal trends.

Technical Documents

Download product inserts and brochures for detailed information.

No technical documents are available at this time. Please check back soon.

Influenza B (Flu B) Antigen Rapid Test